Scotch Corner IPO: What You Should Know Key Project Information Overview

X-twitter Linkedin Facebook-f Vimeo

EDX Medical confirms date for 2025 Annual General Meeting

EDX Medical

EDX Medical Group Plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, has announced that its annual general meeting (AGM) will be held at the Marcus Beck Library, 3rd Floor, Royal School of Medicine, 1 Wimpole Street, Westminster, London, W1G 0AE on 29 September 2025 at 2:00 p.m.

The annual report and financial statements for the year ended 31 March 2025, Notice of AGM and Form of Proxy will be posted today, 1 September 2025, to eligible shareholders. Electronic copies will be shortly available on the Company’s website at: https://edxmedical.co.uk/documents/

Share on:
Find more news, interviews, share price & company profile here for:
Preferred Source

Latest Company News

edx medical

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

EDX Medical Chief Scientific Officer Professor Chris Evans discusses the company’s AIM admission, prostate cancer testing programme in Scotland, and plans to commercialise a range of advanced diagnostic tests.
EDX Medical Group plc

EDX Medical begins trading on AIM following move from Aquis

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its expanding portfolio of personalised healthcare technologies.
EDX Medical Group plc

EDX Medical seeks AIM admission as it prepares to leave Aquis

EDX Medical has announced plans to transfer its ordinary shares from the Aquis Stock Exchange to AIM, with admission and withdrawal expected to take effect simultaneously on 13 May 2026. The company says the move is intended to improve access to growth capital, investor visibility and share liquidity.
edx medical

EDX Medical to lead Scottish Prostate Cancer Testing Initiative

EDX Medical will serve as the primary delivery partner for the Scottish Prostate Cancer Initiative, which plans to offer free PSA testing to 25,000 men across Scotland and explore ways to improve early detection and diagnosis of the disease.
EDX Medical Group plc

EDX Medical raises £3.5m to accelerate prostate cancer programme

EDX Medical Group plc has completed a £3.5 million fundraising from existing high net worth shareholders, issuing 24,999,999 new ordinary shares at 14p per share.
EDX Medical Group plc

EDX Medical reports interim progress with revenue growth expected from diagnostics pipeline

EDX Medical Group has released its interim results for the six months to 20 September 2025, reporting continued progress across its diagnostics portfolio.

Latest interviews

View all interviews 

Company Presentations

View all Company Presentations

BrokersTalk

View all Broker Talk

FTSE 100 News

Search

Green News

View all Sustainable sectors, Plcs and news  

Q&A's

View all Question and Answers

Funds

View all Funds, Market Insights and news

UK Broker Ratings

Hardman & Co

Don't Miss Our News Alerts

Subscribe Free

Find us on:

Linkedin Facebook

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple